Previous Close | 6.70 |
Open | N/A |
Bid | 4.60 |
Ask | 8.90 |
Strike | 40.00 |
Expire Date | 2025-01-17 |
Day's Range | 6.70 - 6.70 |
Contract Range | N/A |
Volume | |
Open Interest | 5 |
On June 3, 2024, Julie Hambleton, Director at SpringWorks Therapeutics Inc (NASDAQ:SWTX), sold 4,648 shares of the company.
Badreddin Edris, the Chief Operating Officer of SpringWorks Therapeutics Inc (NASDAQ:SWTX), sold 20,000 shares of the company on June 3, 2024, according to a recent SEC filing.
On June 3, 2024, Saqib Islam, the Chief Executive Officer of SpringWorks Therapeutics Inc (NASDAQ:SWTX), executed a sale of 49,000 shares of the company.